Hydroxysafflor yellow a confers neuroprotection against acute traumatic brain injury by modulating neuronal autophagy to inhibit NLRP3 inflammasomes.

[1]  Y. Mechref,et al.  Inflammasomes as biomarkers and therapeutic targets in traumatic brain injury and related-neurodegenerative diseases: A comprehensive overview , 2022, Neuroscience & Biobehavioral Reviews.

[2]  Xiaodan Jiang,et al.  Mesenchymal stem cells protect against TBI-induced pyroptosis in vivo and in vitro through TSG-6 , 2022, Cell Communication and Signaling.

[3]  Lin Wang,et al.  Carthamus tinctorius L.: A natural neuroprotective source for anti-Alzheimer's disease drugs. , 2022, Journal of ethnopharmacology.

[4]  Z. Doğanyiğit,et al.  The Role of Neuroinflammatory Mediators in the Pathogenesis of Traumatic Brain Injury: A Narrative Review. , 2022, ACS chemical neuroscience.

[5]  J. P. de Rivero Vaccari,et al.  Inflammatory Biomarkers of Traumatic Brain Injury , 2022, Pharmaceuticals.

[6]  T. Maier,et al.  mTOR substrate phosphorylation in growth control , 2022, Cell.

[7]  Xuehai Wu,et al.  Neuroinflammation Following Traumatic Brain Injury: Take It Seriously or Not , 2022, Frontiers in Immunology.

[8]  Xin Wu,et al.  Sirt1 Attenuates Astrocyte Activation Via Modulating Dnajb1 and Chaperone-Mediated Autophagy After Closed Head Injury. , 2022, Cerebral cortex.

[9]  W. Cerpa,et al.  Traumatic Brain Injury: Mechanisms of Glial Response , 2021, Frontiers in Physiology.

[10]  Q. Cui,et al.  Systematic analysis of the mechanism of hydroxysafflor yellow A for treating ischemic stroke based on network pharmacology technology. , 2021, European journal of pharmacology.

[11]  S. Cuzzocrea,et al.  The inhibition of mammalian target of rapamycin (mTOR) in improving inflammatory response after traumatic brain injury , 2021, Journal of cellular and molecular medicine.

[12]  Zian Xia,et al.  Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury , 2021, Computational and structural biotechnology journal.

[13]  P. Ren,et al.  Hydroxysafflor yellow A acutely attenuates blood-brain barrier permeability, oxidative stress, inflammation and apoptosis in traumatic brain injury in rats , 2021, Acta cirurgica brasileira.

[14]  Xiaofei Zhang,et al.  Network pharmacology exploration reveals a common mechanism in the treatment of cardio-cerebrovascular disease with Salvia miltiorrhiza Burge. and Carthamus tinctorius L , 2020, BMC Complementary Medicine and Therapies.

[15]  Xi-ping Chen,et al.  Autophagy Activation Represses Pyroptosis through the IL-13 and JAK1/STAT1 Pathways in a Mouse Model of Moderate Traumatic Brain Injury. , 2020, ACS chemical neuroscience.

[16]  Yan-Yan Chen,et al.  Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases , 2020, Frontiers in Pharmacology.

[17]  F. Quintana,et al.  Astrocyte Crosstalk in CNS Inflammation , 2020, Neuron.

[18]  Fei Gao,et al.  CNGBdb: China National GeneBank DataBase. , 2020, Yi chuan = Hereditas.

[19]  Hester F. Lingsma,et al.  Clinical characteristics and outcomes in patients with traumatic brain injury in China: a prospective, multicentre, longitudinal, observational study , 2020, The Lancet Neurology.

[20]  Jianhua Fu,et al.  Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy , 2020, Frontiers in Pharmacology.

[21]  James J. McCarthy,et al.  Early versus late profiles of inflammatory cytokines after mild TBI and their association with neuropsychological outcomes. , 2020, Journal of neurotrauma.

[22]  A. Håberg,et al.  Systemic Inflammation Persists the First Year after Mild Traumatic Brain Injury: Results from the Prospective Trondheim Mild Traumatic Brain Injury Study , 2020, Journal of neurotrauma.

[23]  Ruiying Wang,et al.  Hydroxysafflor yellow A inhibits hypoxia/reoxygenation-induced cardiomyocyte injury via regulating the AMPK/NLRP3 inflammasome pathway. , 2020, International immunopharmacology.

[24]  Huifen Chen,et al.  Hydroxysafflor Yellow A Confers Neuroprotection from Focal Cerebral Ischemia by Modulating the Crosstalk Between JAK2/STAT3 and SOCS3 Signaling Pathways , 2020, Cellular and Molecular Neurobiology.

[25]  L. Tao,et al.  The Function and Mechanisms of Autophagy in Traumatic Brain Injury. , 2020, Advances in experimental medicine and biology.

[26]  Chenxia Sheng,et al.  Plasma and cerebrospinal fluid pharmacokinetics of hydroxysafflor yellow A in patients with traumatic brain injury after intravenous administration of Xuebijing using LC-MS/MS method , 2020, Xenobiotica; the fate of foreign compounds in biological systems.

[27]  A. Lee,et al.  Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets , 2019, Front. Cell. Neurosci..

[28]  B. Bibak,et al.  Medicinal plants in traumatic brain injury: Neuroprotective mechanisms revisited , 2019, BioFactors.

[29]  Jace W. Jones,et al.  PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma , 2019, Autophagy.

[30]  Yuhua Chen,et al.  Rapamycin improves the neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI , 2019, Brain Research.

[31]  Guo-yi Gao,et al.  Traumatic brain injury in China , 2019, The Lancet Neurology.

[32]  Mengliang Zhou,et al.  Baicalin Protects Mice Brain From Apoptosis in Traumatic Brain Injury Model Through Activation of Autophagy , 2019, Front. Neurosci..

[33]  Cheng Peng,et al.  Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases , 2018, Evidence-based complementary and alternative medicine : eCAM.

[34]  Fei Li,et al.  Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury , 2018, Neurobiology of Disease.

[35]  A. Bitto,et al.  Lack of the Nlrp3 Inflammasome Improves Mice Recovery Following Traumatic Brain Injury , 2017, Front. Pharmacol..

[36]  P. Dash,et al.  Traumatic brain injury decreases AMP‐activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome , 2016, Journal of neurochemistry.

[37]  Shery Jacob,et al.  A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.

[38]  Yanni Lv,et al.  Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway. , 2015, European journal of pharmacology.

[39]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[40]  S. Salzberg,et al.  StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.

[41]  Han-dong Wang,et al.  Traumatic Brain Injury-Induced Neuronal Apoptosis is Reduced Through Modulation of PI3K and Autophagy Pathways in Mouse by FTY720 , 2015, Cellular and Molecular Neurobiology.

[42]  Melissa D. Laird,et al.  High mobility group box protein‐1 promotes cerebral edema after traumatic brain injury via activation of toll‐like receptor 4 , 2014, Glia.

[43]  Lin Zhu,et al.  Expression of the NLRP3 Inflammasome in Cerebral Cortex After Traumatic Brain Injury in a Rat Model , 2013, Neurochemical Research.

[44]  B. Viollet,et al.  AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.

[45]  S. Ryter,et al.  Autophagy proteins regulate innate immune response by inhibiting NALP3 inflammasome-mediated mitochondrial DNA release , 2010, Nature Immunology.

[46]  H. Dai,et al.  Effects of hydroxysafflor yellow A on the experimental traumatic brain injury in rats , 2010, Journal of Asian natural products research.

[47]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[48]  M. Rosner,et al.  mTOR phosphorylated at S2448 binds to raptor and rictor , 2008, Amino Acids.